Active pharmaceutical ingredient manufacturers, CDMO players, and intermediates suppliers in India's pharma supply chain.
Sectors represented: Healthcare
Increased propensity to outsource manufacturing of intermediates & APIs. ◼Enables asset light model and ability to focus on development of novel products for venture. capital backed start-ups. ◼Provides cost advantages and supply chain efficiencies g of intermediates & APIs. ◼Enables asset light model and ability to focus on development of novel products for venture. capital backed start-ups.
Pharmaceutical Ingredient (API) industry through expanding. manufacturing capabilities, robust regulatory standards. and deeper integration into global pharmaceutical supply. chains. rmaceutical Ingredient (API) industry through expanding. manufacturing capabilities, robust regulatory standards. and deeper integration into global pharmaceutical supply. chains.
We have evolved from an API-focused. organisation into an integrated pharmaceutical company with capabilities. across APIs, PFIs, finished dosages and peptide CDMO operations. ng supply chain dynamics. We have evolved from an API-focused. organisation into an integrated pharmaceutical company with capabilities. across APIs, PFIs, finished dosages and peptide CDMO operations. Over time,.
Growth is driven at one end by the. pharmaceutical sector's steady demand for reliable,. high-quality shells, and at the other by the rapid. expansion of nutraceuticals and wellness products, currents. Growth is driven at one end by the. pharmaceutical sector's steady demand for reliable,. high-quality shells, and at the other by the rapid. expansion of nutraceuticals and wellness products,.
Strategic initiatives. such as the Production-Linked Incentive (PLI) scheme, along. with investments in bulk drug parks and API manufacturing. infrastructure, are enhancing domestic capabilities in active. pharmaceutical ingredient and formulation production,. thereby improving supply chain resilience and reducing. import dependence. infrastructure, are enhancing domestic capabilities in active.
Unichem in its journey of several decades, also have the privilege to partner. with renowned pharmaceutical companies in offering third-party manufacturing services a comprehensive range of pharmaceutical. products tailored to the specific requirements of its clients. This association stands as a testament to its reliability, trustworthiness and. commitment to delivering excellence.
The rising demand for animal protein, increased livestock production, and. growing companion animal populations are driving the need for more veterinary. medicines and, consequently, APIs. Technological Innovations: Advancements in biotechnology, fermentation technology,. and green chemistry are expected to play a key role in the future of veterinary API. manufacturing. equently, APIs.
Manufacturer from India. ➢Our Business Model. ➢Our Key Products and their Application. ➢Our Products. ➢Capex. ➢Our strategy and outlook. ➢Industry Overview. Advanced Pharma intermediate vanced Intermediate. Manufacturer from India. ➢Our Business Model. ➢Our Key Products and their Application. ➢Our Products. ➢Capex. ➢Our strategy and outlook. ➢Industry Overview. Advanced Pharma intermediate.
High-Potency APIs (HPAPIs). HPAPIs represent one of the most technically. demanding API segments. edibility a key. differentiator influencing supplier selection and. contract longevity. . High-Potency APIs (HPAPIs). HPAPIs represent one of the most technically. demanding API segments. The HPAPI market is. projected to grow from ~USD 30 billion in 2025 to. ~USD 48.3 billion by 2033. [6].. .
In addition, 48 products covering critical fermentation-based and chemically synthesised APIs, KSMs and intermediates have been. approved under the scheme to strengthen domestic manufacturing capabilities. 21 cts covering critical fermentation-based and chemically synthesised APIs, KSMs and intermediates have been. approved under the scheme to strengthen domestic manufacturing capabilities. 21. 14...
Alignmentofinterestofallinternal. stakeholders. Long-standing Relationships. Longstandingrelationshipswith. suppliersandcustomers-Cost-efficient,. consistent,sustainablerawmaterial. supplyandrevenue. Cost Leadership. Fromprocurementtoproductiontillsales Long-standing Relationships. Longstandingrelationshipswith. suppliersandcustomers-Cost-efficient,. consistent,sustainablerawmaterial.